<DOC>
	<DOC>NCT02862262</DOC>
	<brief_summary>A three-arm, multi-site clinical evaluation of the ARIES Bordetella Assay for the detection and identification of Bordetella pertussis (B. pertussis) and Bordetella parapertussis (B. parapertussis) nucleic acids in prospectively collected, de-identified, left-over clinical specimens; banked, pre-selected clinical specimens; and contrived specimens.</brief_summary>
	<brief_title>A Multi-Site Clinical Evaluation of the ARIES Bordetella Assay in Symptomatic Patients</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Whooping Cough</mesh_term>
	<mesh_term>Bordetella Infections</mesh_term>
	<criteria>1. The specimen is a nasopharyngeal swab collected using a cleared nasopharyngeal swab and transport medium. 2. The specimen is from an adult or pediatric, male or female subject who is either hospitalized, admitted to a hospital emergency department, visiting an outpatient clinica or resident of a long term care facility. 3. The specimen is from a patient for whom a requisition has been made for B. pertussis and/or B. parapertussis testing. 4. The specimen is from a patient exhibiting clinical signs and symptoms of respiratory tract infection consistent with B. pertussis or B. parapertussis. 5. The specimen was received in good condition (no leakage or drying of the specimen). 6. The specimen contains a minimum volume of 1000 μL. 1. The specimen is not a nasopharyngeal swab collected using a cleared nasopharyngeal swab and transport medium. 2. The specimen was not properly collected, transported, processed or stored according to the instructions provided by the Sponsor in Section 10 below. 3. The specimen volume is &lt;1000 μL. 4. Any specimen that was not tested per the complete testing algorithm provided by the Sponsor.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>